Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study

Authors:
  • AMAlexander von Zur Mühlen
    Alexander von Zur Mühlen
  • CWChristian Wüster
    Christian Wüster
  • MRMichael B. Ranke
    Michael B. Ranke
  • JKJürgen Kratzsch
    Jürgen Kratzsch
  • WKWieland Kiess
    Wieland Kiess
  • JKJean-Marie Ketelslegers
    Jean-Marie Ketelslegers
  • LWLars Wilhelmsen
    Lars Wilhelmsen
  • LHLena Hulthén
    Lena Hulthén
  • BSBernhard Saller
    Bernhard Saller
  • AMAnders Mattsson
    Anders Mattsson
  • JWJürgen Wilde
    Jürgen Wilde

Abstract
Background: Analysis of insulin-like growth factor I in serum (S-IGF-I) is an integral component in the diagnosis of GH-related disorders and is going to be of interest in the diagnosis and follow-up of many disorders. The objective of the present study was to develop cross-sectional reference values for S-IGF-I measured by an automated chemiluminescence immunoassay (Nichols Advantage®). Methods: The study included samples from 3,961 healthy subjects (2,201 males, 1,760 females) aged 1 month to 88 years. Six laboratories were involved in this study and the samples were analyzed by one of seven automated immunoassay systems run in these laboratories. For data analysis, polynomial age and sex-specific models were fitted after transformation of S-IGF-I values. Results: The results show the well-known age dependency of S-IGF-I levels. At ages Conclusion: The present study establishes age- and sex-specific reference values for a fully automated immunoassay system based on a large population of healthy subjects. The established reference values may be used for this immunoassay system in different laboratories provided that the systematic difference between systems is low.

This publication has 12 references indexed in Scilit: